Bank of America’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-500
Closed -$8.27K 8293
2024
Q3
$8.27K Buy
+500
New +$5.48K ﹤0.01% 6921

Other funds holding IGMS

Bank of America's IGMS Position: Q3 2025 in Review

Bank of America sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 8,910 shares — an estimated $9.98K sold.

Bank of America first reported a position in IGMS in Q4 2019 and held it in 23 quarters. The position peaked at $470K in Q4 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

  • Bank of America reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 8,910 IGM Biosciences shares in Q3 2025, an estimated $9.98K.
  • Bank of America first reported a position in IGM Biosciences in Q4 2019 and held it in 23 quarters.
  • Bank of America's IGM Biosciences position peaked at $470K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.